Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10051599HBVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30002905HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30002906HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30082598HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30081552HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30084269HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30046771HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30046772HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20004433HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015710HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TCGA Plot Options
Drug Information
GeneBCL2
DrugBank IDDB08871
Drug NameEribulin
Target IDBE0000246
UniProt IDP10415
Regulation Type
PubMed IDs15313917
CitationsKuznetsov G, Towle MJ, Cheng H, Kawamura T, TenDyke K, Liu D, Kishi Y, Yu MJ, Littlefield BA: Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389. Cancer Res. 2004 Aug 15;64(16):5760-6.
GroupsApproved; Investigational
Direct Classification
SMILES[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2
Pathways
PharmGKB
ChEMBLCHEMBL1683590